Brett Collinge

873 total citations
9 papers, 12 citations indexed

About

Brett Collinge is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Brett Collinge has authored 9 papers receiving a total of 12 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 3 papers in Oncology. Recurrent topics in Brett Collinge's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (3 papers). Brett Collinge is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (3 papers). Brett Collinge collaborates with scholars based in Canada and United States. Brett Collinge's co-authors include Jeffrey W. Craig, Kerry J. Savage, Laurie H. Sehn, Pedro Farinha, Andrew J. Mungall, Christian Steidl, David W. Scott, Diego Villa, Susana Ben‐Neriah and Merrill Boyle and has published in prestigious journals such as Blood, Blood Advances and Hematological Oncology.

In The Last Decade

Brett Collinge

6 papers receiving 12 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett Collinge Canada 2 9 6 5 3 2 9 12
Jack Broadfoot United Kingdom 2 6 0.7× 5 0.8× 10 2.0× 1 0.3× 2 1.0× 4 15
Damien Le Port France 3 6 0.7× 4 0.7× 9 1.8× 2 0.7× 7 3.5× 3 19
William Honeycutt United States 3 14 1.6× 2 0.3× 3 0.6× 5 1.7× 1 0.5× 4 17
Trisha Mandal India 2 9 1.0× 2 0.3× 2 0.4× 8 2.7× 5 10
Elina Tsyvkin United States 3 3 0.3× 5 0.8× 2 0.4× 1 0.3× 2 1.0× 3 9
Felix Hinz Germany 3 16 1.8× 9 1.5× 19 3.8× 9 3.0× 3 1.5× 13 28
Alba Cabirta Spain 3 7 0.8× 4 0.7× 1 0.2× 6 2.0× 9 14
Fabiana Viola Brazil 3 2 0.2× 7 1.2× 3 0.6× 2 0.7× 4 2.0× 5 20
Colleen Dorsey United States 2 7 0.8× 8 1.3× 1 0.3× 2 1.0× 6 11
Lucía Zoppegno Argentina 2 7 0.8× 3 0.5× 1 0.2× 3 1.0× 3 7

Countries citing papers authored by Brett Collinge

Since Specialization
Citations

This map shows the geographic impact of Brett Collinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Collinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Collinge more than expected).

Fields of papers citing papers by Brett Collinge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Collinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Collinge. The network helps show where Brett Collinge may publish in the future.

Co-authorship network of co-authors of Brett Collinge

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Collinge. A scholar is included among the top collaborators of Brett Collinge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Collinge. Brett Collinge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Alduaij, Waleed, Laurie H. Sehn, Brett Collinge, et al.. (2025). Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC / BCL2 rearrangements, DLBCL morphology. Blood Advances. 10(2). 320–333.
2.
Alduaij, Waleed, Aixiang Jiang, Diego Villa, et al.. (2024). CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature–expressing DLBCL. Blood. 145(6). 590–596.
3.
Collinge, Brett, Susana Ben‐Neriah, Laura K. Hilton, et al.. (2024). Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2. Blood. 144(15). 1611–1616. 4 indexed citations
5.
Collinge, Brett, Susana Ben‐Neriah, Laura K. Hilton, et al.. (2022). Do Unbalanced MYC Break-Apart FISH Patterns Indicate the Presence of a MYC Rearrangement?. Blood. 140(Supplement 1). 9244–9246. 1 indexed citations
6.
Hilton, Laura K., Kostiantyn Dreval, Susana Ben‐Neriah, et al.. (2021). Constrained FL: A Genetically Distinct Subgroup of Follicular Lymphoma with Low Rates of Somatic Hypermutation and a Reduced Propensity for Histologic Transformation. Blood. 138(Supplement 1). 807–807.
7.
Dreval, Kostiantyn, Bruno M. Grande, Jasper Wong, et al.. (2021). An Open-Source Toolkit That Powers the Genome-Wide Analysis of Mature B-Cell Lymphomas (GAMBL) Project. Blood. 138(Supplement 1). 1873–1873. 1 indexed citations
8.
Hilton, Laura K., Brett Collinge, Christopher Rushton, et al.. (2021). WHOLE GENOME SEQUENCING OF MATCHED PRIMARY AND RELAPSED DLBCL REVEALS DISTINCT EVOLUTIONARY DYNAMICS ASSOCIATED WITH RELAPSE TIMING. Hematological Oncology. 39(S2). 1 indexed citations
9.
Collinge, Brett, Lauren C. Chong, Susana Ben‐Neriah, et al.. (2017). Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism. Blood. 130. 3994–3994. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026